A 77 years old man is brought to the ER due to a 2-3 days history of altered mental status, cough and shortness of breath associated to fever and non-bloody diarrheas. A month before he had a hospitalization due to seizures, that were attributed to a left frontal meningioma. While admitted he received intravenous steroids and was discharged on dexamethasone while awaiting neurosurgical evaluation. On evaluation he was found hypotensive, tachycardic and tachypneic. His physical exam was unremarkable, although he was disoriented. He had 34% bands, thrombocytopenia, and mild elevation of liver enzymes. His eosinophil's count was normal. A Chest X ray and head CT did not show significant interval changes. He was admitted and started on broad spectrum antibiotics. Initial blood cultures were positive for S. gallolyticus, for which he was consulted for a colonoscopy. The study revealed multiple erythematous skip lesions. Tissue examination demonstrated acute colitis due to Strongyloides stercoralis. Daily treatment with weight-based oral ivermectin was started without response. His clinical course continued deteriorating, developing a widespread urticarial rash, progressive hypoxemic respiratory failure due to cytology confirmed larvae infestation and profound vasopressor-resistant shock. Despite aggressive treatment he died 14 days after admission. Strongyloidiasis is one of the most overlooked helminthic diseases. The clinical course is usually mild or asymptomatic. Subclinical infection may persist for decades since the parasite can complete the entire lifecycle within the human host. The risk of dissemination increases with impaired immunity, underlying malignancy, the administration of cytotoxic drugs, or with the use of steroids as it was in our case. The massive dissemination of the filariform larvae led to profound sepsis, respiratory failure, and death. Even though S. stercolaris is considered a tropical disease, in this globalized era, is important not to underestimate the potentially fatal outcomes of this parasitic infection if undiagnosed, this is very important when providing care to patients coming from endemic areas, and when immunosuppression or corticosteroids are considered in this population at risk. Our case exemplifies the importance of screening for Strongyloidiasis in endemic areas prior to immunosuppression and illustrates the high level of suspicion needed when dealing with an immunocompromised patient with unexplained sepsis.Figure: Colon mucosa with multiple erythematous skip lesions.Figure: Acute colitis with organism consistent with strongyloides parasites.Figure: Urticarial rash.
Read full abstract